Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The COMPASSION-16 trial by Xiaohua Wu and colleagues addresses a crucial need in the management of advanced cervical cancer by evaluating cadonilimab, a novel bispecific antibody targeting PD-1 and ...